← Back to Search

Collaborative Decision Skills Training for Mental Illness (CDST Trial)

N/A

Recruiting

Led By Emily B Treichler, PhD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

having primary substance use or organic neurological disorder diagnosis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change in symptom severity from baseline (month 0) to follow-up at 3-months post-intervention (month 5)

Awards & highlights

No Placebo-Only Group

Summary

This trial will establish the feasibility of Collaborative Decision Skills Training (CDST) among 12 Veterans with serious mental illness (SMI), and compare it to active control (AC) using a randomized clinical trial of 72 Veterans.

Who is the study for?

This trial is for Veterans with serious mental illnesses like schizophrenia and major depressive disorder, who are currently receiving services at the VA San Diego Psychosocial Rehabilitation and Recovery Center. Participants must be willing to have some treatment sessions recorded. Those with high violence risk or primary substance use disorders cannot join.

What is being tested?

The study tests Collaborative Decision Skills Training (CDST), aiming to empower Veterans by improving their decision-making skills in treatment settings. It involves an initial feasibility phase followed by a randomized trial comparing CDST against an active control through group sessions over eight weeks.

What are the potential side effects?

Since this intervention focuses on skill training rather than medication, traditional side effects are not expected. However, there may be psychological discomfort from engaging in new types of interactions or discussing sensitive topics during training.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been diagnosed with a substance use or brain disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change in personal recovery from baseline (month 0) to follow-up at 3-months post-intervention (month 5)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change in personal recovery from baseline (month 0) to follow-up at 3-months post-intervention (month 5)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change in personal recovery from baseline (month 0) to follow-up at 3-months post-intervention (month 5) for reporting.